Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Neurology, Neurosurgery & Psychiatry
Few classes of therapeutics have been specifically developed to combat migraine, despite its global impact on disability. However, after 30 years of translational research, calcitonin gene-related peptide (CGRP) inhibitors have emerged as a promising new tool in the prevention of migraine.
Neurology July 5th 2022
MDLinx
The research shows that chronic pain, inflammatory bowel disease, cancer, and migraines all play a role in the development of mental diseases. Healthcare practitioners should take a careful history and keep in mind comorbidities when treating patients for any of these conditions.
Gastroenterology July 5th 2022